Trillium Therapeutics
TRIL
#4819
Rank
C$2.66 B
Marketcap
C$25.42
Share price
0.00%
Change (1 day)
9,746.24%
Change (1 year)

Earnings for Trillium Therapeutics (TRIL)

Earnings in 2021 (TTM): C$79.98 Million

According to Trillium Therapeutics's latest financial reports the company's current earnings are C$0.23 Million. In 2020 the company made an earning of -C$84.72 Million a decrease over its 2019 earnings that were of -C$49.53 Million.

Earnings history for Trillium Therapeutics from 2005 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)C$79.98 M-194.41%
2020-C$84.72 Million71.05%
2019-C$49.53 Million51.44%
2018-C$32.71 Million-12.31%
2017-C$37.3 Million33.83%
2016-C$27.87 Million133.5%
2015-C$11.94 Million-14.44%
2014-C$13.95 Million165.45%
2013-C$5.26 Million249.29%
2012-C$1.51 Million-65.81%
2011-C$4.4 Million-26.08%
2010-C$5.96 Million12.35%
2009-C$5.3 Million-14.56%
2008-C$6.21 Million-10.01%
2007-C$6.9 Million-241.7%
2006C$4.86 M-268.2%
2005-C$2.9 Million